Evidence map›Paper›PMID 42010944›Full record

ArticleThe oncologist2026

Trajectories of health care contact days experienced by decedents who underwent curative-intent surgery for pancreatic cancer.

Whitney V Johnson, Khalid Ishani, Amy A Gravely, Vishal R Patel, Christopher J LaRocca, David G Brauer, Eric H Jensen, Anders D Westanmo, Arjun Gupta

Abstract read
In one paragraph

Article in The oncologist, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Whitney V JohnsonDepartment of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, United States.
Khalid IshaniDepartment of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, United States.
Amy A GravelyMinneapolis Veterans Affairs Health Care System, Minneapolis, MN, United States.
Vishal R PatelHarvard Medical School, Boston, Massachusetts, United States.
Christopher J LaRoccaDepartment of Surgery, Minneapolis Veterans Affairs Health Care System, Minneapolis, MN, United States.
David G BrauerDepartment of Surgery, University of Minnesota, Minneapolis, MN, United States.
Eric H JensenDepartment of Surgery, University of Minnesota, Minneapolis, MN, United States.
Anders D WestanmoMinneapolis Veterans Affairs Health Care System, Minneapolis, MN, United States.
Arjun GuptaDepartment of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, United States.ORCID 0000-0003-0875-4731

Funding

Pancreatic Cancer Action Network
6 · The paper itself

Abstract

Patients with pancreatic cancer undergoing curative-intent surgery face incredible burdens, even long-term after surgery, but the amount of time spent in health care (ie, as health care contact days) was not hitherto quantified. In this cohort study of 649 patients with pancreatic cancer undergoing curative-intent surgery in the largest integrated health system in the United States, patients spent approximately 50% of days as contact days (and 50% as "home days"-without health care contact) in the first month after surgery. The percentage of home days only increased to approximately 60% even 1 year after surgery when including the approximate mortality 20% rate, and patients spent at least 20% of their days with health care contact even months/years after surgery. These data are important for counseling patients and caregivers (both to set expectations and to augment informed decision-making) and for health systems and policy makers to ensure appropriate supports.

Indexed as

Pancreatic NeoplasmsAgedAged, 80 and overDelivery of Health CareFemaleHumansMaleMiddle AgedTimeUnited Statescontact dayscurativepancreatic cancersurgical resectiontime toxicity

Identifiers

PMID42010944
PMCPMC13131938

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.